These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 24378613)

  • 21. Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme.
    Sunwoo L; Choi SH; Park CK; Kim JW; Yi KS; Lee WJ; Yoon TJ; Song SW; Kim JE; Kim JY; Kim TM; Lee SH; Kim JH; Sohn CH; Park SH; Kim IH; Chang KH
    J Magn Reson Imaging; 2013 Feb; 37(2):351-8. PubMed ID: 23023975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers.
    Svrcek M; Buhard O; Colas C; Coulet F; Dumont S; Massaoudi I; Lamri A; Hamelin R; Cosnes J; Oliveira C; Seruca R; Gaub MP; Legrain M; Collura A; Lascols O; Tiret E; Fléjou JF; Duval A
    Gut; 2010 Nov; 59(11):1516-26. PubMed ID: 20947886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression.
    Uccella S; Cerutti R; Placidi C; Marchet S; Carnevali I; Bernasconi B; Proserpio I; Pinotti G; Tibiletti MG; Furlan D; Capella C
    J Clin Pathol; 2009 Aug; 62(8):715-23. PubMed ID: 19638543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Status of O⁶ -methylguanine-DNA methyltransferase [MGMT] gene promoter methylation among patients with glioblastomas from India.
    Nehru GA; Pai R; Samuel P; Chacko AG; Chacko G
    Neurol India; 2012; 60(5):481-6. PubMed ID: 23135024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methylation status of the MGMT gene promoter fails to predict the clinical outcome of glioblastoma patients treated with ACNU plus cisplatin.
    Park CK; Park SH; Lee SH; Kim CY; Kim DW; Paek SH; Kim DG; Heo DS; Kim IH; Jung HW
    Neuropathology; 2009 Aug; 29(4):443-9. PubMed ID: 19170894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does neoadjuvant therapy alter KRAS and/or MSI results in rectal adenocarcinoma testing?
    Ondrejka SL; Schaeffer DF; Jakubowski MA; Owen DA; Bronner MP
    Am J Surg Pathol; 2011 Sep; 35(9):1327-30. PubMed ID: 21836482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tubular adenomas with minor villous changes show molecular features characteristic of tubulovillous adenomas.
    Ishii T; Notohara K; Umapathy A; Mallitt KA; Chikuba H; Moritani Y; Tanaka N; Rosty C; Matsubara N; Jass J; Leggett B; Whitehall V
    Am J Surg Pathol; 2011 Feb; 35(2):212-20. PubMed ID: 21263241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. O6-methylguanine-DNA Methyltransferase Promoter Methylation in Patients with Rectal Adenocarcinoma After Chemoradiotherapy Treatment: Clinical Implications.
    Oliver JA; Gómez-Millán J; Medina JA; Cabeza L; Perazzoli G; Jimenez-Luna C; Doello K; Ortiz R
    Balkan Med J; 2019 Aug; 36(5):283-286. PubMed ID: 31199091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KRAS mutations and rectal cancer response to chemoradiation: are we closer to personalization of therapy?
    Krishnan S; Chang GJ
    Ann Surg Oncol; 2013 Oct; 20(11):3359-62. PubMed ID: 23864308
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative analysis of radiosensitizers for K-RAS mutant rectal cancers.
    Kleiman LB; Krebs AM; Kim SY; Hong TS; Haigis KM
    PLoS One; 2013; 8(12):e82982. PubMed ID: 24349411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic approach introduced some immune system targets in rectal cancer by considering cell-free DNA methylation in response to radiochemotherapy.
    Bagheri-Hosseinabadi Z; Eshkevari SMS; Khalighfard S; Alizadeh AM; Khori V; Amiriani T; Poorkhani A; Sadani S; Esmati E; Lashgari M; Mahmoodi M; Hajizadeh MR
    Cytokine; 2024 Sep; 181():156666. PubMed ID: 38906038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenome-wide analysis of DNA methylation reveals a rectal cancer-specific epigenomic signature.
    Vymetalkova V; Vodicka P; Pardini B; Rosa F; Levy M; Schneiderova M; Liska V; Vodickova L; Nilsson TK; Farkas SA
    Epigenomics; 2016 Sep; 8(9):1193-207. PubMed ID: 27529132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correction: CRLX101, a Nanoparticle-Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1
    Cancer Res; 2017 Dec; 77(23):6790-6791. PubMed ID: 29196418
    [No Abstract]   [Full Text] [Related]  

  • 34. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
    Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
    Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-free DNA and preoperative chemoradiotherapy for rectal cancer: a systematic review.
    Boysen AK; Schou JV; Spindler KG
    Clin Transl Oncol; 2019 Jul; 21(7):874-880. PubMed ID: 30506526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemo-radiotherapy before surgery in patients with locally advanced rectal cancer.
    Schou JV; Larsen FO; Sørensen BS; Abrantes R; Boysen AK; Johansen JS; Jensen BV; Nielsen DL; Spindler KL
    Ann Oncol; 2018 Mar; 29(3):610-615. PubMed ID: 29253083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing circulating tumour DNA (ctDNA) as a prognostic biomarker in locally advanced rectal cancer: a systematic review and meta-analysis.
    O'Sullivan NJ; Temperley HC; Kyle ET; Sweeney KJ; O'Neill M; Gilham C; O'Sullivan J; O'Kane G; Mehigan B; O'Toole S; Larkin J; Gallagher D; McCormick P; Kelly ME
    Int J Colorectal Dis; 2024 May; 39(1):82. PubMed ID: 38809315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating single-cell and spatial analysis reveals MUC1-mediated cellular crosstalk in mucinous colorectal adenocarcinoma.
    Zhou H; Shen Y; Zheng G; Zhang B; Wang A; Zhang J; Hu H; Lin J; Liu S; Luan X; Zhang W
    Clin Transl Med; 2024 May; 14(5):e1701. PubMed ID: 38778448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Changes in Circulating Cell-Free DNA as an Early Predictor of Response to Chemoradiation in Rectal Cancer-A Pilot Study.
    Ong WL; Lunca S; Morarasu S; Musina AM; Puscasu A; Iacob S; Iftincai I; Marinca A; Ivanov I; Roata CE; Velenciuc N; Dimofte G
    Medicina (Kaunas); 2023 Sep; 59(10):. PubMed ID: 37893461
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.